Elon Musk’s Neuralink filed as ‘disadvantaged business’ before being valued at $9 billion

Elon Musk’s Neuralink filed as ‘disadvantaged business’ before being valued at  billion


Jonathan Raa | Nurphoto | Getty Images

Elon Musk’s health tech company Neuralink labeled itself a “small disadvantaged business” in a federal filing with the U.S. Small Business Administration, shortly before a financing round valued the company at $9 billion.

Neuralink is developing a brain-computer interface (BCI) system, with an initial aim to help people with severe paralysis regain some independence. BCI technology broadly can translate a person’s brain signals into commands that allow them to manipulate external technologies just by thinking.

Neuralink’s filing, dated April 24, would have reached the SBA at a time when Musk was leading the Trump administration’s Department of Government Efficiency. At DOGE, Musk worked to slash the size of federal agencies.

MuskWatch first reported on the details of Neuralink’s April filing.

According to the SBA’s website, a designation of SDB means a company is at least 51% owned and controlled by one or more “disadvantaged” persons who must be “socially disadvantaged and economically disadvantaged.” An SDB designation can also help a business “gain preferential access to federal procurement opportunities,” the SBA website says. 

The Department of Justice has previously fined companies for making false claims about their SDB status.

Musk, the world’s wealthiest person, is CEO of Tesla and SpaceX, in addition to his other businesses like artificial intelligence startup xAI and tunneling venture The Boring Company. In 2022, Musk led the $44 billion purchase of Twitter, which he later named X before merging it with xAI.

Jared Birchall, a Neuralink executive, was listed as the contact person on the filing from April. Birchall, who also manages Musk’s money as head of his family office, didn’t immediately respond to a request for comment.

Neuralink, which incorporated in Nevada, closed a $650 million funding round in early June at a $9 billion valuation. ARK Invest, Peter Thiel’s Founders Fund, Sequoia Capital and Thrive Capital were among the investors. Neuralink said the fresh capital would help the company bring its technology to more patients and develop new devices that “deepen the connection between biological and artificial intelligence.”

Under Musk’s leadership at DOGE, the initiative took aim at government agencies that emphasized diversity, equity and inclusion (DEI). In February, for example, DOGE and Musk boasted of nixing hundreds of millions of dollars worth of funding for the Department of Education that would have gone towards DEI-related training grants.

WATCH: DOGE cuts face congressional test

DOGE cuts face congressional test. Here's a breakdown



Source

Meta, Google, OpenAI among Big Tech firms seeing top staff leaving to launch AI startups
Technology

Meta, Google, OpenAI among Big Tech firms seeing top staff leaving to launch AI startups

Top researchers are jumping ship from Big Tech firms like Meta and Google to launch startups and raise huge funding rounds in the process, as investors bet big on the commercial potential of early-stage AI labs. Amid colossal spending on AI, many of these new startups are raising hundreds of millions within months of being […]

Read More
Cramer calls blistering rally in chip stocks ‘worrisome.’ How he’s protecting his portfolio
Technology

Cramer calls blistering rally in chip stocks ‘worrisome.’ How he’s protecting his portfolio

CNBC’s Jim Cramer said the blistering rally in semiconductor and AI-related stocks may be sending a warning signal about the broader market. “Lately, we’ve been seeing parabolic moves all over the market” said the “Mad Money” host. “Those are worrisome.” His caution comes after a historic run in the Philadelphia Semiconductor Index, often called the […]

Read More
Jim Cramer says this could be the biggest threat to the market’s rally
Technology

Jim Cramer says this could be the biggest threat to the market’s rally

CNBC’s Jim Cramer said one of the biggest overlooked risks to the market is a coming wave of massive initial public offerings that could drain liquidity from stocks. “A bull [market] can also be killed by excess supply — too many big IPOs and it collapses under its own weight,” said the “Mad Money” host […]

Read More